Picture of WuXi Biologics (Cayman) logo

2269 — WuXi Biologics (Cayman) News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapHigh Flyer

Deals of the day-Mergers and acquisitions

Jan 6 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 1430 GMT on Monday:

    ** China's WuXi Biologics  2269.HK  said it will sell its
vaccine facility in Ireland to Merck  MRK.N  for about $500
million.  urn:newsml:reuters.com:*:nL4N3O20PV
    
    ** Teoxane SA offered to acquire Revance Therapeutics
 RVNC.O  for a higher price compared to a buyout offer from
Crown Laboratories last month.  urn:newsml:reuters.com:*:nL4N3O20Y4
    
    ** Walt Disney Co  DIS.N  and sports-focused streaming
provider FuboTV  FUBO.N  have agreed to combine their online
live TV businesses, the companies said.  urn:newsml:reuters.com:*:nL4N3O20S0
    
    ** A takeover offer for Malaysia Airports Holdings  MAHB.KL 
by a consortium comprising the country's sovereign wealth fund
Khazanah and BlackRock's Global Infrastructure Partners has been
extended to Jan. 17 from Jan. 8, a stock filing showed.   
 urn:newsml:reuters.com:*:nL1N3O20FB

    ** Australia's Insignia Financial  IFL.AX  said it has
received a non-binding proposal from CC Capital Partners, LLC to
acquire the firm for A$2.87 billion ($1.78 billion).
 urn:newsml:reuters.com:*:nL4N3O103K

 (Compiled by Rajarshi Roy and Ateev Bhandari in Bengaluru)
 ((ateev.bhandari@thomsonreuters.com))

Recent news on WuXi Biologics (Cayman)

See all news